RUNX2 regulates the effects of TNFα on proliferation and apoptosis in SaOs-2 cells

Bone

Volumn 46, Issue 4, 2010, Pages 901-910

  Olfa, Ghali ^a   Christophe, Chauveau ^a   Philippe, Lencel ^a   Romain, Salomez ^a   Khaled, Hani ^b   Pierre, Hardouin ^a   Odile, Broux ^a   Jean Christophe, Devedjian ^a  

^a UNIV LILLE   (France)

^b Laboratory of biochemistry (UR/08 45)   (Tunisia)

Author keywords

Apoptosis; Proliferation; RUNX2; SaOs 2; TNF

Indexed keywords

CYCLIN A1; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E1; CYCLINE; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL FATE; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA CELL; TRANSGENE;

EID: 77950541745     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.12.027     Document Type: Article

References (46)

1. Otto F., Lubbert M., Stock M. Upstream and downstream targets of RUNX proteins. J. Cell. Biochem. 2003, 89:9-18.
2. Wee H.J., Huang G., Shigesada K., Ito Y. Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Rep. 2002, 3:967-974.
3. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10431-10434.
4. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
5. Guo W.H., Weng L.Q., Ito K., Chen L.F., Nakanishi H., Tatematsu M., et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 2002, 21:8351-8355.
6. Torquati A., O'Rear L., Longobardi L., Spagnoli A., Richards W.O., Daniel Beauchamp R. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. Surgery 2004, 136:310-316.
7. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997, 89:773-779.
8. Pratap J., Galindo M., Zaidi S.K., Vradii D., Bhat B.M., Robinson J.A., et al. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res. 2003, 63:5357-5362.
9. Cameron E.R., Blyth K., Hanlon L., Kilbey A., Mackay N., Stewart M., et al. The Runx genes as dominant oncogenes. Blood Cells. Mol. Dis. 2003, 30:194-200.
10. Thomas D.M., Johnson S.A., Sims N.A., Trivett M.K., Slavin J.L., Rubin B.P., et al. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J. Cell. Biol. 2004, 167:925-934.
11. Galindo M., Pratap J., Young D.W., Hovhannisyan H., Im H.J., Choi J.Y., et al. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J. Biol. Chem. 2005, 280:20274-20285.
12. Young D.W., Hassan M.Q., Pratap J., Galindo M., Zaidi S.K., Lee S.H., et al. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 2007, 445:442-446.
13. Zaidi S.K., Pande S., Pratap J., Gaur T., Grigoriu S., Ali S.A., et al. Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19861-19866.
14. Eliseev R.A., Dong Y.F., Sampson E., Zuscik M.J., Schwarz E.M., O'Keefe R.J., et al. Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis. Oncogene 2008, 27:3605-3614.
15. Bertaux K., Broux O., Chauveau C., Jeanfils J., Devedjian J.C. Identification of CBFA1-regulated genes on SaOs-2 cells. J. Bone Miner. Metab. 2005, 23:114-122.
16. Bertaux K., Broux O., Chauveau C., Hardouin P., Jeanfils J., Devedjian J.C. Runx2 regulates the expression of GNAS on SaOs-2 cells. Bone 2006, 38:943-950.
17. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., et al. Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999, 13:1025-1036.
18. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current Protocols in Molecular Biology. John Wiley & Sons, Inc., New York 1987.
19. Smith E., Frenkel B., MacLachlan T.K., Giordano A., Stein J.L., Lian J.B., et al. Post-proliferative cyclin E-associated kinase activity in differentiated osteoblasts: inhibition by proliferating osteoblasts and osteosarcoma cells. J. Cell. Biochem. 1997, 66:141-152.
20. Miller C.W., Aslo A., Campbell M.J., Kawamata N., Lampkin B.C., Koeffler H.P. Alterations of the p15, p16, and p18 genes in osteosarcoma. Cancer Genet. Cytogenet. 1996, 86:136-142.
21. Kilbey A., Blyth K., Wotton S., Terry A., Jenkins A., Bell M., et al. Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Res. 2007, 67:11263-11271.
22. Kansara M., Thomas D.M. Molecular pathogenesis of osteosarcoma. DNA Cell. Biol. 2007, 26:1-18.
23. Thomas D.M., Carty S.A., Piscopo D.M., Lee J.S., Wang W.F., Forrester W.C., et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol. Cell. 2001, 8:303-316.
24. Musat M., Vax V.V., Borboli N., Gueorguiev M., Bonner S., Korbonits M., et al. Cell cycle dysregulation in pituitary oncogenesis. Front. Horm. Res. 2004, 32:34-62.
25. Forget A., Ayrault O., den Besten W., Kuo M.L., Sherr C.J., Roussel M.F. Differential post-transcriptional regulation of two Ink4 proteins, p18(Ink4c) and p19(Ink4d). Cell. Cycle 2008, 7.
26. Kim S.A., Kim S.W., Chang S., Yoon J.H., Ahn S.G. 5'-Nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells. Cancer Lett. 2008.
27. Kouraklis G., Katsoulis I.E., Theocharis S., Tsourouflis G., Xipolitas N., Glinavou A., et al. Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?. Dig. Dis. Sci. 2008.
28. Gilbert L., He X., Farmer P., Rubin J., Drissi H., van Wijnen A.J., et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J. Biol. Chem. 2002, 277:2695-2701.
29. Nanes M.S. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003, 321:1-15.
30. Hock J.M., Krishnan V., Onyia J.E., Bidwell J.P., Milas J., Stanislaus D. Osteoblast apoptosis and bone turnover. J. Bone Miner. Res. 2001, 16:975-984.
31. Jilka R.L., Weinstein R.S., Bellido T., Parfitt A.M., Manolagas S.C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner. Res. 1998, 13:793-802.
32. Kitajima I., Soejima Y., Takasaki I., Beppu H., Tokioka T., Maruyama I. Ceramide-induced nuclear translocation of NF-kappa B is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone 1996, 19:263-270.
33. Tsuboi M., Kawakami A., Nakashima T., Matsuoka N., Urayama S., Kawabe Y., et al. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J. Lab. Clin. Med. 1999, 134:222-231.
34. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell. Biol. 2001, 11:372-377.
35. Dechant M.J., Fellenberg J., Scheuerpflug C.G., Ewerbeck V., Debatin K.M. Mutation analysis of the apoptotic "death-receptors" and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines. Int. J. Cancer 2004, 109:661-667.
36. Nakayama Y., Kato N., Nakajima Y., Shimizu E., Ogata Y. Effect of TNF-alpha on human osteosarcoma cell line Saos2-TNF-alpha regulation of bone sialoprotein gene expression in Saos2 osteoblast-like cells. Cell. Biol. Int. 2004, 28:653-660.
37. Akter R., Rivas D., Geneau G., Drissi H., Duque G. Effect of lamin A/C knockdown on osteoblast differentiation and function. J Bone Miner Res 2009 Feb, 24:283-293.
38. Platt I.D., El-Sohemy A. Regulation of osteoblast and adipocyte differentiation from human mesenchymal stem cells by conjugated linoleic acid. J Nutr Biochem 2009 Dec, 20:956-964.
39. Pucci B., Bertani F., Karpinich N.O., Indelicato M., Russo M.A., Farber J.L., et al. Detailing the role of Bax translocation, cytochrome c release, and perinuclear clustering of the mitochondria in the killing of HeLa cells by TNF. J. Cell. Physiol. 2008, 217:442-449.
40. Hellwig C.T., Kohler B.F., Lehtivarjo A.K., Dussmann H., Courtney M.J., Prehn J.H., et al. Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand/cycloheximide-induced caspase activities during apoptosis initiation. J. Biol. Chem. 2008, 283:21676-21685.
41. Xia Y., Novak R., Lewis J., Duckett C.S., Phillips A.C. Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP. Mol. Cell. Biochem. 2006, 286:67-76.
42. Mikami T., Koyama T., Koyama T., Imakiire A., Yamamoto K., Furuhata M., et al. C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines. Anticancer Res. 2006, 26:1153-1160.
43. Bellido T., Ali A.A., Plotkin L.I., Fu Q., Gubrij I., Roberson P.K., et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J. Biol. Chem. 2003, 278:50259-50272.
44. Tintut Y., Parhami F., Le V., Karsenty G., Demer L.L. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J. Biol. Chem. 1999, 274:28875-28879.
45. Blyth K., Cameron E.R., Neil J.C. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer 2005, 5:376-387.
46. Flores M.V., Lam E.Y., Crosier P., Crosier K. A hierarchy of Runx transcription factors modulate the onset of chondrogenesis in craniofacial endochondral bones in zebrafish. Dev. Dyn. 2006, 235:3166-3176.